Published in Arch Surg on December 01, 1992
Sentinel lymph node biopsy in the management of patients with primary cutaneous melanoma: review of a large single-institutional experience with an emphasis on recurrence. Ann Surg (2001) 1.36
Adjuvant radiation therapy in metastatic lymph nodes from melanoma. Radiat Oncol (2011) 0.82
Liver metastases of unknown primary: malignant melanoma. Case Reports Hepatol (2014) 0.75
Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol (2001) 10.20
Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. J Clin Oncol (2001) 9.68
Liver resection for colorectal metastases. J Clin Oncol (1997) 4.88
Radical surgery for gastric cancer. A review of the Japanese experience. Cancer (1989) 2.91
Lymph node metastasis from soft tissue sarcoma in adults. Analysis of data from a prospective database of 1772 sarcoma patients. Ann Surg (1993) 2.87
Alpha-factor-directed synthesis and secretion of mature foreign proteins in Saccharomyces cerevisiae. Proc Natl Acad Sci U S A (1984) 2.74
Surgery for melanoma metastatic to the gastrointestinal tract. Ann Surg Oncol (1999) 2.61
Prospective randomized clinical trial of the value of intraperitoneal drainage after pancreatic resection. Ann Surg (2001) 2.47
Sentinel lymph node biopsy in breast cancer: initial experience at Memorial Sloan-Kettering Cancer Center. J Am Coll Surg (1998) 2.32
Improved staging of node-negative patients with intermediate to thick melanomas (>1 mm) with the use of lymphatic mapping and sentinel lymph node biopsy. Ann Surg Oncol (2001) 2.19
Management of primary and recurrent soft-tissue sarcoma of the retroperitoneum. Ann Surg (1990) 2.17
The role of surgery in the treatment of clinically isolated adrenal metastasis. Cancer (1998) 1.97
Patterns of detection in patients with cutaneous melanoma. Cancer (2000) 1.97
Merkel cell carcinoma. Prognosis and management. Arch Surg (1991) 1.72
A new American Joint Committee on Cancer staging system for cutaneous melanoma. Cancer (2000) 1.52
The prognostic impact of isolated tumor cells in lymph nodes of T2N0 gastric cancer: comparison of American and Japanese gastric cancer patients. Ann Surg Oncol (2009) 1.50
The value of minimal access surgery in the staging of patients with potentially resectable peripancreatic malignancy. Ann Surg (1996) 1.50
Surgical oncology fellowship: viable pathway to academic surgery? Ann Surg Oncol (1999) 1.46
Is intra-abdominal drainage necessary after pancreaticoduodenectomy? J Gastrointest Surg (1999) 1.45
Detection of tyrosinase mRNA by reverse transcription-polymerase chain reaction in melanoma sentinel nodes. Ann Surg Oncol (1999) 1.44
The malignant nature of papillary and cystic neoplasm of the pancreas. Cancer (1991) 1.42
Sentinel lymph node biopsy in the management of patients with primary cutaneous melanoma: review of a large single-institutional experience with an emphasis on recurrence. Ann Surg (2001) 1.36
Desmoplastic small round cell tumors: prognostic indicators and results of surgical management. Ann Surg Oncol (1998) 1.35
Subcutaneously implanted central venous access devices in cancer patients: a prospective analysis. Cancer (1997) 1.31
Does the extent of operation influence the prognosis in patients with melanoma metastatic to inguinal nodes? Ann Surg Oncol (1999) 1.26
Melanoma metastatic to stomach, small bowel, or colon. Am J Surg (1991) 1.24
Surgical management of Merkel cell carcinoma. Ann Surg (1999) 1.21
Sentinel lymph node biopsy for melanoma: controversy despite widespread agreement. J Clin Oncol (2001) 1.10
Recurrence and survival after pathologic complete response to preoperative therapy followed by surgery for gastric or gastrooesophageal adenocarcinoma. Br J Cancer (2011) 1.01
Direct observations of surgical wound infections at a comprehensive cancer center. Arch Surg (1995) 1.00
Intraoperative lymphatic mapping and sentinel lymph node biopsy for Merkel cell carcinoma. Br J Surg (1999) 0.98
Hepatic metastases from soft-tissue sarcoma. Ann Surg (1995) 0.96
Immunohistochemical analysis of sentinel lymph nodes from patients with Merkel cell carcinoma. Cancer (2001) 0.95
Major amputation for advanced malignant melanoma. Surg Gynecol Obstet (1989) 0.94
A phase II trial of neoadjuvant cisplatin-fluorouracil followed by postoperative intraperitoneal floxuridine-leucovorin in patients with locally advanced gastric cancer. Ann Oncol (2006) 0.93
Transcutaneously tunneled central venous lines in cancer patients: an analysis of device-related morbidity factors based on prospective data collection. Ann Surg Oncol (2000) 0.91
Axillary dissection in melanoma. Prognostic variables in node-positive patients. Ann Surg (1990) 0.91
Computed tomography in evaluation of patients with stage III melanoma. Ann Surg Oncol (1997) 0.86
Phase II trial of neoadjuvant temozolomide in resectable melanoma patients. Ann Oncol (2010) 0.85
Phase I evaluation of a combination of monoclonal antibody R24 and interleukin 2 in patients with metastatic melanoma. Cancer Res (1990) 0.85
Indications for and efficacy of splenectomy for haematological disorders. Br J Surg (2013) 0.83
Melanoma. A multidisciplinary approach for the general surgeon. Surg Clin North Am (2000) 0.82
Prognosis of thick cutaneous melanoma. J Am Coll Surg (1999) 0.81
Role of elective lymph node dissection in melanoma. Semin Surg Oncol (1998) 0.81
Early recurrence after lymphatic mapping and sentinel node biopsy in patients with primary extremity melanoma: a comparison with elective lymph node dissection. Ann Surg Oncol (2001) 0.80
Association of positive transection margins with gastric cancer survival and local recurrence. Ann Surg Oncol (2013) 0.80
Sentinel lymph node evaluation in melanoma. Arch Dermatol (1997) 0.79
Preoperative chemotherapy does not influence the number of evaluable lymph nodes in resected gastric cancer. Eur J Surg Oncol (2012) 0.78
Focal nodular hyperplasia of the liver. Surg Gynecol Obstet (1990) 0.78
Staging work-up and post-treatment surveillance of patients with melanoma. Clin Plast Surg (2000) 0.77
Reverse transcriptase polymerase chain reaction (RT-PCR) detection of melanoma-related transcripts in the peripheral blood and bone marrow of patients with malignant melanoma. What have we learned? Recent Results Cancer Res (2001) 0.77
Peritoneovenous shunting for nongynecologic malignant ascites. Cancer (2001) 0.77
Merkel cell carcinoma. Aust N Z J Surg (1999) 0.76
The "true" sentinel lymph node: in search of an operational definition of a biological phenomenon. Ann Surg Oncol (2001) 0.75
Lymphatic mapping in the management of melanoma in children. Pediatr Dermatol (1999) 0.75
Association between molecular detection of GAGE and survival in patients with malignant melanoma: a retrospective cohort study. Clin Cancer Res (1999) 0.75
Adjuvant therapy of malignant melanoma. Surg Oncol Clin N Am (1997) 0.75